Max Rosett - Chief Financial Officer at Immunome Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Financial Officer
Issuer Symbol
IMNM on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Max Rosett since 20 Jan 2025

Holdings reported by Max Rosett for Immunome Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 47,476 $760,091 $16.01 19 Sep 2024 Direct
Employee Stock Option (right to buy) 207,000 29 Jul 2025 Direct Common Stock
Stock option (right to buy) 91,848 19 Sep 2024 Direct Common Stock

Transactions reported by Max Rosett for Immunome Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.